Retraction notice to "Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16" [Life Sci. 225 (2019) 55-63]
Life Sci. 2020 Sep 1:256:117903.
doi: 10.1016/j.lfs.2020.117903.
Epub 2020 Jun 18.